Recently, endoscopic ultrasonography (EUS)-guided ethanol ablation for small pancreatic neuroendocrine tumors (p-NETs) has been reported. However, the efficacy and safety of the technique remain unclear. We have launched a prospective pilot study of EUS-guided ethanol ablation for p-NETs. The major eligibility criteria are the presence of a pathologically diagnosed grade (G) 1 or G2 p-NET, a tumor size of ≤2cm, and being a poor candidate for surgery. A total of 5 patients will be treated. The primary endpoint will be the complete ablation rate at 1 month after treatment.
|Number of pages||4|
|Journal||Acta Medica Okayama|
|Publication status||Published - 2016|
- Ethanol ablation
- Pancreatic neuroendocrine tumor
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)